Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Advanced Accelerator Applications closes €41mm late-stage round

Executive Summary

Advanced Accelerator Applications SA (developing radiopharmaceuticals and diagnostic imaging agents) raised €41mm ($56mm) in what looks to be its Series F financing. HBM Healthcare Investments led the round providing €20 million. Tamburi Investment Partners Group also participated along with undisclosed new and returning shareholders. Funds will support ongoing development of molecular nuclear medicine diagnostics and therapeutics including Phase III Lutathera for gastro-entero-pancreatic neuro endocrine tumors.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Molecular Imaging
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies